Treatment with dopamine-receptor agonists is associated with impulse control disorders, including pathological gambling, binge eating, and hypersexuality. Patients and their carers should be …

Pipexus 0.26mg modified-release tablets Ethypharm UK Ltd Show Cautionary and advisory labels. Label . 10 Warning: Read the additional information given with this medicine. Rhybudd: …

Pramipexole causes somnolence and episodes of sudden sleep onset in some people, and, uncommonly, without awareness or warning. People should exercise caution while driving or …

Pipexus is used to treat the symptoms of primary Parkinson’s disease in adults. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease). 2. What you …

Mar 28, 2023 · Pramipexole is available as immediate-release tablets and as prolonged-release tablets. The immediate-release tablets can be taken by people with Parkinson's disease or …

Jan 29, 2025 · Pipexus prolonged-release tablets are a once-a-day oral formulation of pramipexole. Initial treatment Doses should be increased gradually from a starting dose of …

Jun 7, 2018 · bnf: 04090100; gtin: 5060078670067 If you find that some of the information provided is incorrect or you are looking for documents that are not available at this time, you …

Pipexus is indicated in adults for treatment of the signs and symptoms of idiopathic Parkinson’s di­sease, alone (without levodopa) or in combination with levodopa, i.e. over the course of the …

Jan 7, 2025 · Pipexus is a nonergot-derivative dopamine receptor agonist which alleviates Parkinsonian motor deficits by directly stimulating postsynaptic dopamine activity on the …

Pipexus is used to treat the symptoms of primary Parkinson’s disease in adults. It can be used alone or in combination with levodopa (another medicine for Parkinson’s disease). 2.